BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anondita Medicare IPO is Open!
Apply for the Anondita Medicare IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

531015

VENMAX

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VENMAX DRUGS AND PHARMACEUTICA Share Price Update

As of the latest trading session, VENMAX DRUGS AND PHARMACEUTICA share price is currently at ₹ 31.6, which is up by ₹ 2.49 from its previous closing. Today, the stock has fluctuated between ₹ 29.50 and ₹ 31.79. Over the past year, VENMAX DRUGS AND PHARMACEUTICA has achieved a return of 342.24 %. In the last month alone, the return has been 5.66 %. Read More...

Investment Returns

Over 1 Month 5.66% Over 3 Months 7.85% Over 6 Months 19.80% Over 1 Year 342.24%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VENMAX DRUGS AND PHARMACEUTICA fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    16.30

  • P/E Ratio (TTM)

    1,036.33

  • Beta

    0.07

  • Book Value / share

    8.37

  • Return on equity

    1.15%

  • EPS (TTM)

    0.03

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.04

info icon alternate text

VENMAX DRUGS AND PHARMACEUTICA Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 1.21
Operating Expense 1.17
Net Profit 0.04
Net Profit Margin (%) 3.30
Earnings Per Share (EPS) 0.07
EBITDA 0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.33
Operating Expense 0.58
Net Profit 0.78
Net Profit Margin (%) 236.36
Earnings Per Share (EPS) 1.49
EBITDA 0.77
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.20
Operating Expense 0.69
Net Profit -0.50
Net Profit Margin (%) -250.00
Earnings Per Share (EPS) -0.95
EBITDA -0.50
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.17
Operating Expense 0.47
Net Profit -0.30
Net Profit Margin (%) -176.47
Earnings Per Share (EPS) -0.58
EBITDA -0.30
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.10
Operating Expense 0.12
Net Profit 0.01
Net Profit Margin (%) 10.00
Earnings Per Share (EPS) 0.02
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.81
Operating Expense 1.87
Net Profit -0.01
Net Profit Margin (%) -1.23
Earnings Per Share (EPS) -0.02
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit 0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.12
EBITDA 0.09
Effective Tax Rate (%) 22.22
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit 0.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.43
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit 1.85
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 3.52
EBITDA 1.86
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.17
Operating Expense 0.51
Net Profit -0.16
Net Profit Margin (%) -94.11
Earnings Per Share (EPS) -0.31
EBITDA -0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -1.24
ROE % 1.15
ROCE % 1.43
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.36
ROE % 4.10
ROCE % 3.86
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.79
ROE % 116.35
ROCE % 63.14
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -5.32
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -88.24
Particulars MAR 2020 (Values in Cr)
Book Value / Share -5.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -53.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.08
Total Liabilities 0.08
Total Equity -0.65
Share Outstanding 5238930
Price to Book Ratio 0.00
Return on Assets (%) 79.23
Return on Capital (%) -21.64
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.21
Total Liabilities 0.21
Total Equity -0.71
Share Outstanding 5238930
Price to Book Ratio 0.00
Return on Assets (%) 106.71
Return on Capital (%) -62.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.21
Total Liabilities 0.21
Total Equity -0.94
Share Outstanding 5238930
Price to Book Ratio 0.00
Return on Assets (%) 864.37
Return on Capital (%) -312.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 0.30
Total Liabilities 0.30
Total Equity -2.78
Share Outstanding 5238930
Price to Book Ratio 0.00
Return on Assets (%) -52.82
Return on Capital (%) 35.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.45
Total Liabilities 0.45
Total Equity -2.62
Share Outstanding 5238930
Price to Book Ratio 0.00
Return on Assets (%) -60.00
Return on Capital (%) 260.82
Particulars MAR 2024 (Values in Cr)
Net Income 0.08
Cash from Operations 0.02
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.02
Particulars MAR 2023 (Values in Cr)
Net Income 0.22
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 1.84
Cash from Operations 1.90
Cash from Investing 0.00
Cash from Financing -1.98
Net change in Cash -0.07
Free Cash Flow 1.90
Particulars MAR 2021 (Values in Cr)
Net Income -0.16
Cash from Operations 0.26
Cash from Investing 0.00
Cash from Financing -0.18
Net change in Cash 0.07
Free Cash Flow 0.26
Particulars MAR 2020 (Values in Cr)
Net Income -0.26
Cash from Operations -0.27
Cash from Investing 0.00
Cash from Financing 0.27
Net change in Cash 0.00
Free Cash Flow -0.27
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 34.22 13.97 1.87 262.24 30.00 / 69.75
BLISS GVS PHARMA LTD 166.55 16.47 1.67 1757.06 105.05 / 190.65
CIPLA LTD 1545.85 23.16 4.00 124866.66 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 342.40 9.64 2.77 1007.72 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2785.40 49.83 24.18 47186.36 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 34.22 18.60 5.40 262.24 30.00 / 69.75
AMRUTAJAN HEALTH LTD 722.05 38.28 6.39 2087.49 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8450.65 99.90 27.42 21126.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 166.55 24.90 1.65 1757.06 105.05 / 190.65

VENMAX DRUGS AND PHARMACEUTICA Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
31.09 6.80 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 29.60
  • 26 Days 28.00
  • 10 Days 29.10
  • 50 Days 27.20
  • 12 Days 28.90
  • 100 Days 25.90
  • 20 Days 28.30
  • 200 Days 22.20
29.37 PIVOT

First Support

28.73

First Resistance

29.73

Second Support

28.37

Second Resistance

30.37

Third Support

27.73

Third Resistance

30.73

RSI

58.40

ADX

30.59

MACD

0.73

Williams % R

-31.25

Commodity Channel Index (CCI)

97.49

Date

2025-08-20

Week

4249.00

Same Day

5584.00

Month

11535.00

1 Year

0.12

3 Year

0.03

Over 1 Month

5.66%

down

Over 1 Year

342.24%

down

Over 3 Months

7.85%

down

Over 3 Years

0.00%

down

Over 6 Months

19.80%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

VENMAX DRUGS AND PHARMACEUTICA shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

VENMAX DRUGS AND PHARMACEUTICA corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

VENMAX DRUGS AND PHARMACEUTICA Share Price

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It became a Public Limited Company on February 3, 1995 with 'Yenkey Drugs & Pharmaceuticals Limited'. Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009.

For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). Initially, the Company engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is engaged in the business of IT & ITES services.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

Venmax Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 31.09 as on Aug 22 2025 03:29 PM.

What is the Market Cap of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Venmax Drugs & Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 16.30 as on Aug 22 2025 03:29 PM.

What is the 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 31.95 and ₹ 6.27.

What is 1 year return for Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 372.49%.

What is the P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Aug 22 2025 03:29 PM the price-to-earnings (PE) ratio for Venmax Drugs & Pharmaceuticals Ltd share is 1036.33.

What is the PB ratio of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Aug 22 2025 03:29 PM, the price-to-book (PB) ratio for Venmax Drugs & Pharmaceuticals Ltd share is 8.37.

How to Buy Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Venmax Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Venmax Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Venmax Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Venmax Drugs & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91